Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of ranolazine and ivabradine on angina status and quality of life in patients with microvascular angina

Trial Profile

Effects of ranolazine and ivabradine on angina status and quality of life in patients with microvascular angina

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ivabradine (Primary) ; Ranolazine (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use

Most Recent Events

  • 11 Sep 2012 New trial record
  • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top